A phase I study of binimetinib, a MEK inhibitor, in combination with pembrolizumab in patients with advanced non-small cell lung cancer (NSCLC)

被引:2
|
作者
Theriau, Christopher F.
Feng, Jamie
Eng, Lawson
Shepherd, Frances A.
DeCarolis, Mary
Glenns, Vivian
Kulkarni, Swati
VanderMeer, Rachel
Zurawska-Fortin, Urszula
Hao, Desiree
Le, Lisa
Wozniczka, Isabel
Al-Kindy, Aida
Xie, Danny
Zhang, Tong
Subramanian, Vasanth
Stockley, Tracy
Bradbury, Penelope A.
Liu, Geoffrey
Leighl, Natasha B.
机构
关键词
D O I
10.1158/1538-7445.AM2023-CT206
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CT206
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Outcome predictors for pembrolizumab alone or with chemotherapy in advanced non-small cell lung cancer (NSCLC)
    Zullo, L.
    Cella, E.
    Paoloni, F.
    Gualtieri, M.
    Barletta, G.
    Favero, D.
    Parisi, F.
    Dellepiane, C.
    Rossi, G.
    Bennicelli, E.
    Zinoli, L.
    Cantini, L.
    Pecci, F.
    Del Mastro, L.
    Berardi, R.
    Genova, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S78 - S79
  • [32] A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
    Michael A Morse
    Jennifer Garst
    Takuya Osada
    Shubi Khan
    Amy Hobeika
    Timothy M Clay
    Nancy Valente
    Revati Shreeniwas
    Mary Ann Sutton
    Alain Delcayre
    Di-Hwei Hsu
    Jean-Bernard Le Pecq
    H Kim Lyerly
    Journal of Translational Medicine, 3
  • [33] A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
    Morse, MA
    Garst, J
    Osada, T
    Khan, S
    Hobeika, A
    Clay, TM
    Valente, N
    Shreeniwas, R
    Sutton, MA
    Delcayre, A
    Hsu, DH
    Le Pecq, JB
    Lyerly, HK
    JOURNAL OF TRANSLATIONAL MEDICINE, 2005, 3 (1)
  • [34] Phase I study of ridaforolimus with cetuximab for patients with advanced non-small cell lung cancer (NSCLC), colorectal cancer, and head and neck cancer
    Taber, Angela Marie
    Khurshid, Humera
    Perez, Kimberly
    Birnbaum, Ariel E.
    Olszewski, Adam J.
    Luppe, Denise
    Jean, Maureen
    Rosati, Kayla
    Safran, Howard
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] A phase I/II study of pembrolizumab (P) with gemcitabine (G) in patients (Pts) with previously-treated advanced non-small cell lung cancer (NSCLC): Phase I safety results
    Sanborn, Rachel E.
    Duffy, Regan M.
    Fisher, Brenda K.
    Perlewitz, Kelly Shea
    Redmond, William L.
    Koguchi, Yoshinobu
    Fox, Bernard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy (CRT) in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
    Tanaka, K.
    Okamoto, I.
    Yamamoto, N.
    Hattori, Y.
    Masuda, N.
    Nishio, M.
    Takeda, K.
    Seto, T.
    Nishimura, Y.
    Nakagawa, K.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S605 - S605
  • [37] Phase II study of paclitaxel (Genaxol®) and cisplatin combination in treating Chinese patients with advanced non-small cell lung cancer (NSCLC)
    Chen, CH
    Chang, WC
    Lin, MC
    Hsu, JW
    Chao, TY
    Tsao, TCY
    LUNG CANCER, 2002, 38 (01) : 91 - 96
  • [38] Phase II study of Docetaxel (D) and Carboplatin (C) combination in advanced Non-Small Cell Lung Cancer (NSCLC)
    Chowdhury, Qamruzzaman
    Begum, Ferdous A.
    Nahar, Ferdous
    Fairuz, Saima
    Faruqui, Mesba
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S673 - S673
  • [39] BIOMARKER DEVELOPMENT FOR A PHASE II STUDY OF COMBINATION EPIGENETIC THERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Wrangle, John M.
    Juergens, Rosalyn A.
    Vendetti, Frank
    Coleman, Barbara
    Sebree, Rosa
    Rudek, Michelle
    Herman, James
    Rudin, Charles
    Brock, Malcolm V.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1101 - S1101
  • [40] Sunitinib in Combination With Erlotinib for the Treatment of Advanced/Metastatic Non-small Cell Lung Cancer (NSCLC): a Phase III Study
    Govindan, R.
    Krzakowski, M. J.
    Szczesna, A.
    Strausz, J.
    Makhson, A. N.
    Reck, M.
    Tye, L.
    Zhang, K.
    Chao, R. C.
    Scagliotti, G. V.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S557 - S557